20 May 2013
Keywords: Johnson & Johnson, Pfizer, Legal costs, Risperdal, Prempro, M&A, Teva, Taiyo
Article | 16 May 2011
According to press reports emerging ahead of the weekend, two US drug giants, Pfizer (NYSE: PFE) and Johnsons & Johnson ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 May 2011
17 May 2011
17 May 2013
© 2013 thepharmaletter.com